44 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof"-"UNIS" Postdoctoral positions at Yale University in United States
-
in immunology and / or cancer biology research and the development of new cancer therapies. Experience with in vivo immunotherapy models, mRNA therapeutics, functional genomics and the use of CRISPR
-
platform development for respiratory and non-respiratory pathogens. The Israelow lab has recently opened in the Department of Internal Medicine in the Section of Infectious Diseases at the Yale School
-
School of Medicine (www.patel-lab.org). Our laboratory has a highly translational focus, with the overall goal of developing non-invasive diagnostic tools for early detection and surveillance of cancer
-
independently and collaboratively, desiring to develop and/or adapt novel approaches in biochemistry, molecules and genetics, and PhD in Neuroscience and related disciplines. However, auditory and hearing
-
project We are seeking highly motivated postdoctoral researchers in biomedical informatics and data science to work on projects focused on the development of biomedical blockchain, clinical predictive
-
that activate kinases by removing phosphate groups, playing crucial roles in both physiological processes and various diseases. Developing drugs that target MKPs is challenging due to the nearly identical
-
a particular focus on cytokine-based drugs, using immune competent murine models and human cell culture systems for early drug development. We also study mechanisms and determinants of immune related
-
environment. Ability to mentor and train junior team members in both clinical and molecular techniques. Commitment to maintaining high standards of laboratory safety and regulatory compliance. Experience with
-
Postdoctoral Associate in Computational Neuroscience at Yale The Post-Doctoral Associate will develop predictive, gene-regulatory networks linked to Parkinson’s and other neurological diseases in
-
are one of the most exciting areas of cancer biology. Many novel strategies for targeting RAS are in clinical trial, and many more are in development and are advancing to clinical trials. The Stites lab’s